ConductScience.org, home

Paper46019

Cyclophosphamide treatment in steroid-sensitive nephrotic syndrome of childhood.

Barratt TM and 3 others. Lancet, 1975. Cited by 70 papers, by iCite.

Cite this record

ConductScience Library. Cyclophosphamide treatment in steroid-sensitive nephrotic syndrome of childhood. Papers, record 46019. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/46019

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cyclophosphamide treatment in steroid-sensitive nephrotic syndrome of childhood.
PubMed
Journal
Lancet
PubMed
Year
1975
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
70
iCite
Relative citation ratio, by iCite
4.34
iCite
Revised in PubMed
2019-06-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Barratt TMT M
2Bercowsky AA
3Osofsky SGS G
4Soothill JFJ F

Source PubMed

Download CSV of authors

Topics25

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CyclophosphamideMajor topic
Nephrotic SyndromeMajor topic
PrednisoloneMajor topic
Administration, Oral
Adolescent
Albuminuria
Body Height
Body Weight
Child
Child, Preschool
Complement System Proteins
Creatine
Drug Resistance
Drug Therapy, Combination
Female
Humans
Immunodiffusion
Immunoglobulin G
Infant
Leukocyte Count
Male
Proteinuria
Recurrence
Remission, Spontaneous
Time Factors

Source PubMed

Download CSV of topics

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 70 citations.

PMIDTitleJournalYearIn PapersSource
36625931The first randomized controlled trial in pediatric nephrology: the history of the International Study of Kidney Disease in Children (ISKDC).Pediatr Nephrol2023https://conductscience.org/library/papers/36625931PubMed
21394465Cyclophosphamide in steroid-dependent nephrotic syndrome.Pediatr Nephrol2011https://conductscience.org/library/papers/21394465PubMed
16186679Treatment of steroid sensitive nephrotic syndrome.Indian J Pediatr2005https://conductscience.org/library/papers/16186679PubMed
12883981The use of steroid-sparing agents in steroid-sensitive nephrotic syndrome.Pediatr Nephrol2003https://conductscience.org/library/papers/12883981PubMed
12750975Cyclophosphamide in steroid-sensitive nephrotic syndrome: outcome and outlook.Pediatr Nephrol2003https://conductscience.org/library/papers/12750975PubMed
7870636Cyclosporin A in refractory idiopathic nephrotic syndrome: 5 years clinical experience.Postgrad Med J1994https://conductscience.org/library/papers/7870636PubMed
7726612Alternative treatment to corticosteroids in steroid sensitive idiopathic nephrotic syndrome.Arch Dis Child1994https://conductscience.org/library/papers/7726612PubMed
7337968The effect of chronic daily cyclophosphamide administration on established antibody responses.Clin Exp Immunol1981https://conductscience.org/library/papers/7337968PubMed
3740921Minimal change nephrotic syndrome and cyclophosphamide.Arch Dis Child1986https://conductscience.org/library/papers/3740921PubMed
3688915Cyclophosphamide treatment of steroid dependent nephrotic syndrome: comparison of eight week with 12 week course. Report of Arbeitsgemeinschaft für Pädiatrische Nephrologie.Arch Dis Child1987https://conductscience.org/library/papers/3688915PubMed
3391218Cyclophosphamide in treatment of minimal change nephrotic syndrome.Eur J Pediatr1988https://conductscience.org/library/papers/3391218PubMed
2701868Immunosuppressive therapy in the nephrotic syndrome in children.Pediatr Nephrol1989https://conductscience.org/library/papers/2701868PubMed
2248508Eight and 12 week courses of cyclophosphamide in nephrotic syndrome.Arch Dis Child1990https://conductscience.org/library/papers/2248508PubMed
2053810Eight and 12 week courses of cyclophosphamide in nephrotic syndrome.Arch Dis Child1991https://conductscience.org/library/papers/2053810PubMed
1911150Kidney biopsy prior to cyclophosphamide therapy in primary nephrotic syndrome.Pediatr Nephrol1991https://conductscience.org/library/papers/1911150PubMed
1718684Management of nephrotic syndrome in childhood.Drugs1991https://conductscience.org/library/papers/1718684PubMed
1536727Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial. The French Society of Paediatric Nephrology.Pediatr Nephrol1992https://conductscience.org/library/papers/1536727PubMed
941352Vascular absorption of intravesical formalin in cyclophosphamide induced haemorrhagic cystitis.Urol Res1976https://conductscience.org/library/papers/941352PubMed
783212Problems with immunosuppressive agents in renal disease.J Clin Pathol Suppl (R Coll Pathol)1975https://conductscience.org/library/papers/783212PubMed
316687Nephrotic syndrome of childhood: malaria therapy reconsidered.Arch Dis Child1979https://conductscience.org/library/papers/316687PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/46019

GET https://conductscience.org/api/papers/v1/46019/authors